logo

Other Programs

Other IOmet Programs
Outside of its small molecule programs developing inhibitors of IDO, TDO and GLUT1, IOmet is pursuing a number of other undisclosed cancer immunotherapy and cancer metabolism targets, in addition to a GLUT9 inhibitor program for the treatment of gout.